These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 36742399)

  • 1. Prognosis comparison between small cell carcinoma of ovary and high-grade serous ovarian cancer: A retrospective observational cohort study.
    Hu D; Ma D; Zhang ZJ; Zhang Y; Huang K; Li X
    Front Endocrinol (Lausanne); 2023; 14():1103429. PubMed ID: 36742399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between complex epithelial neoplasms of the ovary and high-grade serous ovarian cancer: a retrospective observational cohort study.
    Li X; Ding Y; Liu Y; Yang M
    J Ovarian Res; 2022 Dec; 15(1):125. PubMed ID: 36456989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphadenectomy Benefits Small Cell Carcinoma of Ovary: A Population-Based Analysis.
    Wang J; Ning Y; Du Y; Kang Y
    Curr Oncol; 2022 Oct; 29(10):7802-7815. PubMed ID: 36290894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Characteristics and Outcomes Between Large-Cell Neuroendocrine Carcinoma of the Ovary and High-Grade Serous Ovarian Cancer: A Retrospective Observational Cohort Study.
    Pang L; Guo Z
    Front Oncol; 2022; 12():891699. PubMed ID: 35600342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving population-based statistics for rare epithelial ovarian cancers.
    Matsuo K; Machida H; Matsuzaki S; Grubbs BH; Klar M; Roman LD; Sood AK; Gershenson DM; Wright JD
    Gynecol Oncol; 2020 Apr; 157(1):3-11. PubMed ID: 31954534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based Analysis of the Clinical Features of Primary Small Cell Carcinoma of the Ovary.
    Jamy O; Yaghmour G; Hare F; Martin MG
    Anticancer Res; 2015 May; 35(5):3091-5. PubMed ID: 25964600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel prognostic nomograms to assess survival in high-grade serous ovarian carcinoma after surgery and chemotherapy: a retrospective cohort study from SEER database.
    Huang W; Bao Y; Luo X; Yao L; Yuan L
    Ann Transl Med; 2022 Jul; 10(13):728. PubMed ID: 35957727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small Cell Carcinoma of the Ovary: Clinicopathologic and Immunohistochemical Analysis of 7 New Cases of a Rare Malignancy.
    Gupta P; Kapatia G; Gupta N; Dey P; Rohilla M; Gupta A; Rai B; Suri V; Rajwanshi A; Srinivasan R
    Int J Surg Pathol; 2021 May; 29(3):236-245. PubMed ID: 32772748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.
    Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
    J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and identification of a prognostic nomogram model for patients with mixed cell adenocarcinoma of the ovary.
    Wu H; Jiang S; Zhong P; Li W; Zhang S
    J Ovarian Res; 2021 Oct; 14(1):137. PubMed ID: 34674727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic alterations in neuroendocrine cancers of the ovary.
    Yaghmour G; Prouet P; Wiedower E; Jamy OH; Feldman R; Chandler JC; Pandey M; Martin MG
    J Ovarian Res; 2016 Aug; 9(1):52. PubMed ID: 27566252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of clinical characteristics and prognosis of endometrioid ovarian cancer based on the SEER database and two centers in China.
    Chen S; Lu H; Jiang S; Li M; Weng H; Zhu J; Zhang T; Wang Y; Zhao W; Wu D; Shen Z; Yang Z; Zhou Y
    BMC Cancer; 2023 Jul; 23(1):608. PubMed ID: 37391693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic characteristics and survival outcomes in neuroendocrine carcinoma of the ovary.
    Zhu Y; Meng F; Fang H; Zhang Z; Wang L; Zheng W
    Int J Gynecol Cancer; 2020 Feb; 30(2):207-212. PubMed ID: 31796530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Transitional Cell Carcinoma-Like Morphology of High-Grade Serous Ovarian Carcinoma: A Comparative Study.
    Nasioudis D; Sisti G; Kanninen TT; Fambrini M; Di Tommaso M
    Int J Gynecol Cancer; 2016 Nov; 26(9):1624-1629. PubMed ID: 27575630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the clinical characteristics and prognosis between clear cell carcinomas and high-grade serous ovarian carcinomas.
    Dong S; Yu F; Liu Y; Yu X; Sun X; Wang W; Wang Y
    Ginekol Pol; 2023; 94(10):792-798. PubMed ID: 36477777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.
    Wang B; Wang S; Ren W
    BMC Cancer; 2021 May; 21(1):609. PubMed ID: 34034697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical characteristics and outcomes of cases with pure ovarian clear cell, mixed type and high-grade serous adenocarcinoma.
    Kucukgoz Gulec U; Paydas S; Guzel AB; Vardar MA; Khatib G; Gumurdulu D
    Arch Gynecol Obstet; 2015 Oct; 292(4):923-9. PubMed ID: 25855053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis prediction and comparison between pancreatic signet ring cell carcinoma and pancreatic duct adenocarcinoma: a retrospective observational study.
    Zhou H; Li XX; Huang YP; Wang YX; Zou H; Xiong L; Liu ZT; Wen Y; Zhang ZJ
    Front Endocrinol (Lausanne); 2023; 14():1205594. PubMed ID: 37534212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candidate prognostic biomarkers and prediction models for high-grade serous ovarian cancer from urinary proteomics.
    Ni M; Wan D; Wu J; Gong W; Wang J; Zheng Z
    J Proteomics; 2024 Jul; 304():105234. PubMed ID: 38925351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Survival Among Histological Subtypes in Advanced Epithelial Ovarian Cancer: Population-Based Study Using the Surveillance, Epidemiology, and End Results Database.
    Yang SP; Su HL; Chen XB; Hua L; Chen JX; Hu M; Lei J; Wu SG; Zhou J
    JMIR Public Health Surveill; 2021 Nov; 7(11):e25976. PubMed ID: 34787583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.